Pyramidatine
Pyramidatine (Haplamidine) is a P-glycoprotein inhibitor with an IC50 of 39.29 µM. As a sensitizer, Pyramidatine enhances Vincristine (HY-N0488A)-induced Apoptosis and G2/M phase arrest, while potentiating the activity of Vincristine against drug-resistant oral cancer. Pyramidatine can be used in research related to oral cancer and mammary adenocarcinoma.
For research use only. We do not sell to patients.
- CAS No.: 64223-54-7
- Formula: C20H22N2O2
- Molecular Weight:322.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Pyramidatine (10 µM; 24 h) enhances VCR-induced apoptosis in KB/VCR cells, increasing the apoptotic rate to 31.31% when used at 10 µM in combination with 0.2 µM VCR for 24 h[1].
Pyramidatine (10 µM; 48 h) upregulates pro-apoptotic marker expression in KB/VCR cells when used at 10 µM in combination with 0.2 µM VCR for 48 h[1].
Pyramidatine (10 µM; 24 h) enhances VCR-induced G2/M arrest in KB/VCR cells, resulting in 97.44% of cells arrested in G2/M phase when used at 10 µM in combination with 0.2 µM VCR for 24 h[1].
Pyramidatine inhibits Verapamil (HY-14275)-stimulated P-gp ATPase activity in recombinant human P-gp membranes with an IC50 of 39.29 µM[1].
Pyramidatine (10 µM; 36 h) suppresses P-gp protein expression in KB/VCR cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:KB/VCR cells
-
Concentration:10 µM (alone); 10 µM (combined with 0.2 µM VCR)
-
Incubation Time:24 h
-
Result:Induced 6.59% apoptosis in KB/VCR cells when used alone at 10 µM.
Increased the apoptotic rate to 31.31% when combined with 0.2 µM VCR, which was 2.13-fold higher than VCR alone (14.73%) and higher than the verapamil-positive control combination (21.83%).
-
Cell Line:KB/VCR cells
-
Concentration:10 µM (alone); 10 µM (combined with 0.2 µM VCR)
-
Incubation Time:48 h
-
Result:Significantly increased the expression of cleaved PARP and pro-apoptotic Bax protein in KB/VCR cells when combined with 0.2 µM VCR.
-
Cell Line:KB/VCR cells
-
Concentration:10 µM (alone); 10 µM (combined with 0.2 µM VCR)
-
Incubation Time:24 h
-
Result:Resulted in 22.41% of KB/VCR cells arrested in G2/M phase when used alone at 10 µM.
Increased the G2/M arrest rate to 97.44% when combined with 0.2 µM VCR, which was higher than VCR alone (63.18%) and the verapamil-positive control combination (89.57%).
-
Cell Line:KB/VCR cells
-
Concentration:10 µM (alone); 10 µM (combined with 0.2 µM VCR)
-
Incubation Time:24 h
-
Result:Increased cyclin B1 protein expression in KB/VCR cells when combined with 0.2 µM VCR.
-
Cell Line:KB/VCR cells
-
Concentration:10 µM
-
Incubation Time:36 h
-
Result:Significantly decreased P-gp protein expression in KB/VCR cells, which naturally overexpress P-gp compared to parental KB cells.
Chemical Information
-
CAS No. 64223-54-7
-
Molecular Weight 322.41
-
Formula C20H22N2O2
-
SMILES
C(NCCCCNC(/C=C/C1=CC=CC=C1)=O)(=O)C2=CC=CC=C2
-
Synonyms
Haplamidine
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
Purity & Documentation
References
[1]. Liu Z, et al. Pyramidatine (Z88) Sensitizes Vincristine-Resistant Human Oral Cancer (KB/VCR) Cells to Chemotherapeutic Agents by Inhibition of P-glycoprotein. Anti-cancer agents in medicinal chemistry. 2018;18(2):286-294. [Content Brief]
[2]. Saifah E, et al. Bisamides from Aglaia species: structure analysis and potential to reverse drug resistance with cultured cells. Journal of natural products. 1993 Apr;56(4):473-7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)